Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SCYNEXIS Q2 EPS $(0.22) Up From $(0.64) YoY

SCYNEXIS (NASDAQ:SCYX) reported quarterly losses of $(0.22) per share. This is a 65.63 percent increase over losses of $(0.64) per share from the same period last year.

byBill Haddad

August 16, 2021

1 minute read

SCYNEXIS (NASDAQ:SCYX) reported quarterly losses of $(0.22) per share. This is a 65.63 percent increase over losses of $(0.64) per share from the same period last year.

Mizuho Maintains Neutral on Toast, Lowers Price Target to $24

By Benzinga Newsdesk

Today, 5:33 AM

Mizuho analyst Dan Dolev maintains Toast (NYSE:TOST) with a Neutral and lowers the price target from $43 to $24.

TOST

US Stocks Mixed; Dow Drops 200 Points

By Lisa Levin

Today, 5:33 AM

U.S. stocks traded mixed this morning, with the Dow Jones dropping around 200 points on Wednesday.

API

Axonics Announces FDA Approval Of Enhanced Neurostimulator Programmer

By Benzinga Newsdesk

Today, 5:33 AM

Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable…

AXNX

JMP Securities Maintains Market Outperform on TriplePoint Venture Gwth, Raises Price Target to $19

By Benzinga Newsdesk

Today, 5:33 AM

JMP Securities analyst Devin Ryan maintains TriplePoint Venture Gwth (NYSE:TPVG) with a Market Outperform and raises the price target from $16.5 to $19.

TPVG

SCYNEXIS Q2 EPS $(0.22) Up From $(0.64) YoY

Related Posts

Mizuho Maintains Neutral on Toast, Lowers Price Target to $24

US Stocks Mixed; Dow Drops 200 Points

Axonics Announces FDA Approval Of Enhanced Neurostimulator Programmer

JMP Securities Maintains Market Outperform on TriplePoint Venture Gwth, Raises Price Target to $19